RNAimmune Competitors and Similar CompaniesClear all
RNAimmune's competitors and similar companies include Uvax Bio, Stemirna and CureVac.
 Uvax Bio Uvax Bio is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology. | ||||
Founding Date | Founding Date 2020 | Founding Date 2018 | Founding Date 2016 | Founding Date 2000 |
Type | Type Subsidiary | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Germantown, US HQ | Locations Wilmington, US HQ | Locations Shanghai, CN HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US |
Employees | Employees 128% decrease | Employees 1110% increase | Employees N/A | Employees 82517% decrease |
Operating ⚠ | ||||
Patent Applications | Patent Applications N/A | Patent Applications N/A | Patent Applications 2 (May, 2020) | Patent Applications 500 (Mar, 2020) |
Patents Issued | Patents Issued N/A | Patents Issued 1 (May, 2020) | Patents Issued 2 (May, 2020) | Patents Issued 233 (May, 2020) |
Funding | ||||
Total funding raised | Total funding raised $ 12.4m | Total funding raised N/A | Total funding raised $ 206.5m | Total funding raised $ 1.1b |
For sources of this data, please see the company profile
View Company Profiles
Uvax Bio
HQ
Wilmington, US
Employees
11↑ 10% increase
Uvax Bio is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology.
View company
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company